efficacy of glp 1 receptor agonists Evaluating the and Safety Long-Acting GLP-1 in T1DM Patients Efficacy and Safety of Glucagon-Like

J Physiol Pharmacol (2021) 72(6):96573

J Clin Gastroenterol 2021;55:586-93.PubMed 111

In May 2023, Pfizer released the results of a Phase 2b clinical trial of the drug

Koehler JA, Baggio LL, Cao X, Abdulla T, Campbell JE, Secher T, Jelsing J, Larsen B, and Drucker DJ

This work set out to discover how GLP-1 mitigates cholesterol-induced lipotoxicity in hepatocytes and what mechanisms are at play in this process

The research community around SeekPeptides has been actively following developments in both the insulin and GLP-1 spaces, and understanding the pharmacological differences is essential for informed research